We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Jagannath - BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Sundar Jagannath, MD
Mount Sinai Medical Center
New York, New York, USA
12.06.11

Be the first to comment

 related articles